Lupin, Zydus Lifesciences ink licensing and supply pact for Saroglitazar Mg

Saroglitazar Mg, approved by the DCGI, is an innovative drug from Zydus to treat chronic liver diseases, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steato Hepatitis (NASH).

Related Keywords

India ,Nilesh Gupta ,Sharvil Patel ,Lupin Ltd ,Zydus Lifesciences Ltd ,Managing Director Nilesh Gupta ,Managing Director Sharvil Patel ,Lupin ,Zydus Lifesciences ,Saroglitazar Mg ,Cgi ,Non Alcoholic Fatty Liver Disease Nafld ,On Alcoholic Steato Hepatitis Nash , ,